Your prediction
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc. | - | - | - | - | - | - | - |
| Simulations Plus | 2.440% | -3.077% | 24.752% | -65.946% | -18.182% | -65.946% | -76.667% |
| Fonar Corp. New | 0.000% | 1.266% | 0.629% | 42.857% | 2.564% | 15.108% | 11.888% |
| MicroVision Inc | -1.440% | -6.252% | 5.981% | -46.216% | -26.964% | -69.701% | -96.339% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat